We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Immune system overview
- Innate immunity
- Adaptive immunity
- Pathogenesis of SLE
- Major players in SLE: innate immunity
- Interferon type 1 (IFN-I)
- IFN-I in SLE
- Two independent type 1 IFN producing pathways
- IFN-I: extrinsic-induced pathway
- IFN-I: intrinsic-induced pathway
- Plasmacytoid dendritic cells (pDCs)
- Lupus-pDC characteristics
- Neutrophils
- Lupus neutrophils
- Low-density granulocytes
- NETosis (Neutrophil extracellular traps)
- NETs in lupus
- Complement system
- Complements in SLE
- Major players in SLE: adaptive immunity
- T-cells - function
- T-cells in SLE
- Adaptive autoimmunity: B cells - function
- B-cells in SLE
- Autoantibodies
Topics Covered
- Overview of innate and adaptive immunity
- Specific effectors of innate immunity in SLE
- Specific effectors of adaptive immunity in SLE
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Putterman, C. and Schwartz, N. (2019, March 31). Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 8, 2024, from https://doi.org/10.69645/RDYA4066.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Chaim Putterman, Investigator role with Exagen and research support from Boerhinger Ingelheim.
- Dr. Noa Schwartz, NIH T32AR071302-01 training grant to the Hospital for Special Surgery Research Institute Rheumatology Training Program
Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1
Published on March 31, 2019
24 min
A selection of talks on Immunology
Transcript
Please wait while the transcript is being prepared...
0:00
Ladies and gentlemen, my name is Chaim Putterman.
It gives me great pleasure to introduce to you today's lecture titled
"Systemic Lupus Erythematosus," or SLE,
with a focus on "Novel Aspects of Pathogenesis and Treatment."
This is an update of a lecture that I provided several years ago to Henry Stewart Talks.
There's been a tremendous amount of progress,
both in understanding pathogenesis of lupus and in treatment modalities,
and we thought it was time to update and provide the new information.
Today's talk is being given by Noa Schwartz from the Hospital for Special Surgery,
and myself, Chaim Putterman,
from the Albert Einstein College of Medicine and Montefiore Medical Center in New York.
0:46
Systemic Lupus Erythematosus, or lupus,
is an autoimmune systemic disease that can affect many organ systems in many different ways.
While previously it was thought to be primarily antibody-driven,
it is now known that all parts of the immune system
contribute to the pathogenesis of the disease.
Therefore, before we go on to discuss
what goes wrong in the immune system of lupus patients,
we would like to briefly first present a general overview of the healthy immune system,
its main players, and some of its regulatory processes.
It is important to emphasize that we do not intend to present here
an exhaustive description of the intricacies of the immune system,
but rather to provide a basic,
yet, we hope, insightful, understanding,
of the main players that are thought to be related to the pathogenesis of lupus.
So the immune system is divided into innate immunity and adaptive immunity.
The innate immune system is considered the first line of defense against pathogens.
It is always there providing universal protection
without a need for priming to begin working effectively.
Adaptive immunity, however, is pathogen- or antigen-specific
and usually more potent but requires priming prior to activation.
Therefore, it takes more time to reach its full protective potential.
Hide